Third Eye Retroscope Randomized Clinical Evaluation

Not Applicable

Completed

Conditions: Colorectal Neoplasms

Interventions: Device: Third Eye Retroscope

Registration Number: NCT01044732

Lead Sponsor: Avantis Medical Systems

Brief Summary: The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon, and might detect additional polyps that cannot be seen with the colonoscope alone.

Patients who participate as subjects in the study will undergo two complete colonoscopy procedures, a standard colonoscopy and a colonoscopy in which a Third Eye Retroscope is used along with the same colonoscope. Half of the patients will have the standard colonoscopy first followed by the Third Eye colonoscopy, and the other half will have the Third Eye procedure first.

Results from the two groups will be analyzed and compared to determine the effectiveness of the Third Eye Retroscope for detecting additional adenomas and other polyps compared with the standard colonoscope alone.

Detailed Description: Colonoscopy is generally agreed to be the best method for detecting and removing pre-cancerous polyps, but some lesions can be missed, especially if they are located behind folds in the lining of the colon or behind flexures (sharp bends) in the colon.

The Third Eye® Retroscope® is a device that can be inserted through the instrument channel of a standard colonoscope to provide an additional, retrograde (or backward) view that reveals areas behind folds and flexures in the colon. Previous studies have shown the device to be effective for detecting additional polyps that could not have been seen with the colonoscope alone.

The purpose of this research is to compare the additional diagnostic yield obtained by using the Third Eye® Retroscope® vs. the diagnostic yield for the standard colonoscope alone in the context of a randomized, controlled study design.

Patients who are scheduled for colonoscopy will be recruited to the study and randomized to one of two groups. Each patient will undergo two "back-to-back" procedures.

Patients in Group A (study group) will undergo a standard colonoscopy followed immediately by a Third Eye colonoscopy.

Patients in Group B (control group) will undergo a Third Eye colonoscopy followed immediately by a standard colonoscopy.

Results from the two groups will be analyzed and compared to determine the effectiveness of the Third Eye Retroscope for detecting additional adenomas and other polyps compared with the standard colonoscope alone.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 448

Inclusion Criteria

The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
The patient must understand and provide written consent for the procedure.

Exclusion Criteria

Patients with a history of colonic resection;
Patients with inflammatory bowel disease;
Patients with a personal history of polyposis syndrome;
Patients with suspected chronic stricture potentially precluding complete colonoscopy;
Patients with diverticulitis or toxic megacolon;
Patients with a history of radiation therapy to abdomen or pelvis;
Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

Study & Design

Study Type: INTERVENTIONAL

Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Group A - COLO, then TER	Third Eye Retroscope	Complete examination with standard colonoscope ("COLO") followed by complete examination with Third Eye Retroscope ("TER") used in conjunction with standard colonoscope
Group B - TER, then COLO	Third Eye Retroscope	Complete examination with Third Eye Retroscope ("TER") used in conjunction with standard colonoscope, followed by complete examination with standard colonoscope ("COLO") alone

Primary Outcome Measures

Name	Time	Method
Detection Rates for Adenomas and for Total Polyps	Acute - subjects were followed for the duration of the procedures, an average of 40 minutes.	Numbers of polyps and adenomas detected in first and second procedures for each group

Secondary Outcome Measures

Name	Time	Method
Times for Withdrawal Phase and for Complete Procedure	Acute - subjects were followed for the duration of the procedures, an average of 40 minutes.	For all examinations with each method (SC or TEC), mean time for withdrawal phase and mean time for total procedure

Trial Locations

Locations (9): Baylor University Medical Center
🇺🇸
Dallas, Texas, United States
Bayside Endoscopy Center
🇺🇸
Providence, Rhode Island, United States
Johns Hopkins Hospital
🇺🇸
Baltimore, Maryland, United States
Dartmouth-Hitchcock Medical Center
🇺🇸
Lebanon, New Hampshire, United States
Kansas City Veterans Administration Medical Center
🇺🇸
Kansas City, Missouri, United States
Cliniques Universitaires Saint-Luc
🇧🇪
Brussels, Belgium
Istituto Clinico Humanitas
🇮🇹
Milan, Italy
St. Mark's Hospital
🇬🇧
London, United Kingdom
University Medical Center Utrecht
🇳🇱
Utrecht, Netherlands